You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | n/a | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -2.6% |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | n/a | 0.0 |
| PEG | n/a | -999,999.0 |
| Price / Revenue | n/a | 10.0 |
| Price / Book value | n/a |
| Latest | Forecast | |
|---|---|---|
| Revenue | 197.7% | 42.7% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -84.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-05-31 | 0.17 | -8.55 | -12.97p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-05-31 | 0.51 | -9.78 | -13.36p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| Oncimmune inks research deal with Dana-Farber Cancer Institute Sharecast News | 23 Jul |
|---|---|
| Oncimmune FY revenues tracking in line with expectations Sharecast News | 08 Jun |
| Oncimmune secures contracts with Roche and Cedars-Sinai Sharecast News | 06 Apr |
| Agreement signed with major cancer center | 23-Jul-21 07:00 |
|---|---|
| Validation of ImmunoINSIGHTS service in COVID-19 | 22-Jul-21 07:00 |
| Total Voting Rights | 01-Jul-21 07:00 |
| Full Year Trading Update | 08-Jun-21 07:00 |
| Notice of FY21 Trading Update | 28-May-21 07:30 |